未登录

G

Gilberto Gerra

ausl parma

H指数:53

被引数:7,805

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Peer Relationships and Psychosocial Difficulties in Adolescents: Evidence from a Clinical Pediatric Sample

青少年同伴关系与心理社会困难：来自临床儿科样本的证据

Journal of Clinical Medicine

IF2.9

2026-03-030

OAAI

Impact of UNODC/WHO S-O-S (stop-overdose-safely) training on opioid overdose knowledge and attitudes among people at high or low risk of opioid overdose in Kazakhstan, Kyrgyzstan, Tajikistan and Ukraine

HARM REDUCTION JOURNAL

IF4

2025-02-200

OA

Commentary on Computational approaches to modeling gambling behaviour: Opportunities for understanding disordered gambling

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

IF7.9

2023-10-010

PRE

Prescription psychostimulants for cocaine use disorder: A review from molecular basis to clinical approach

ADDICTION BIOLOGY

IF2.6

2023-03-017

PRE

Evidence-based Treatment for Stimulant Use Disorder: Time to Hit the Community

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

IF3.8

2022-12-303

OA

Continuing Increase in Stimulant Dependence - Time to Implement Medical Treatment

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

IF3.8

2022-03-148

OA

Early parent-child interactions and substance use disorder: An attachment perspective on a biopsychosocial entanglement

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

IF7.9

2021-12-0113

PRE

Alcohol use disorders among adult children of alcoholics (ACOAs): Gene-environment resilience factors

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2021-06-019

OAAI

Managing dual disorders: a statement by the Informal Scientific Network,UNCommission on Narcotic Drugs

WORLD PSYCHIATRY

IF65.8

2020-09-1524

OAAI

Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis

PSYCHOPHARMACOLOGY

IF3.3

2020-06-2993

PREAI

Addressing the opioid crisis globally

WORLD PSYCHIATRY

IF65.8

2019-05-0645

OAAI

Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2018-04-0153

OAAI

Drug use disorders: impact of a public health rather than a criminal justice approach

WORLD PSYCHIATRY

IF65.8

2017-05-1288

OAAI

Increased oxytocin levels among abstinent heroin addicts: Association with aggressiveness, psychiatric symptoms and perceived childhood neglect

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2017-04-0124

PREAI

Co-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs

PSYCHIATRY RESEARCH

IF3.9

2017-04-0129

OAAI

Perceived parental care during childhood, ACTH, cortisol and nicotine dependence in the adult

PSYCHIATRY RESEARCH

IF3.9

2016-11-018

PREAI

Analysis of γ-hydroxy butyrate by combining capillary electrophoresis-indirect detection and wall dynamic coating: application to dried matrices

ANALYTICAL AND BIOANALYTICAL CHEMISTRY

IF3.8

2015-10-0113

PREAI

Take-home emergency naloxone to prevent deaths from heroin overdose

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2014-11-0423

PREAI

Multi-matrix assay of cortisol, cortisone and corticosterone using a combined MEPS-HPLC procedure

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2014-01-0127

PREAI

Association between gene variants and response to buprenorphine maintenance treatment

PSYCHIATRY RESEARCH

IF3.9

2014-01-0118

PRE